What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Internal medicine
- Bacteria
His primary scientific interests are in Microbiology, Antibacterial agent, Antibiotics, Clindamycin and Anaerobic bacteria.
His study on Microbiology is mostly dedicated to connecting different topics, such as Virology.
His research in Antibacterial agent intersects with topics in Pharmacokinetics, Surgery, Macrolide Antibiotics, Saliva and Linezolid.
His Antibiotics study incorporates themes from Microbiome and Oral administration.
His Clindamycin study integrates concerns from other disciplines, such as Diarrhea and Bacteroides fragilis.
His research integrates issues of Ecology, Amoxicillin, Bacteroides, Clostridia and Anaerobic exercise in his study of Anaerobic bacteria.
His most cited work include:
- Effect of antimicrobial agents on the ecological balance of human microflora. (636 citations)
- Lack of development of new antimicrobial drugs: a potential serious threat to public health. (402 citations)
- Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study (365 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Microbiology, Antibiotics, Anaerobic bacteria, Internal medicine and Antibacterial agent.
His Microbiology research incorporates elements of Anaerobic exercise and Bacteroides.
His Antibiotics research is multidisciplinary, relying on both Feces and Chemotherapy.
His studies in Anaerobic bacteria integrate themes in fields like Amoxicillin and Clostridium perfringens.
Carl Erik Nord has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His biological study spans a wide range of topics, including Oral administration and Pharmacokinetics.
He most often published in these fields:
- Microbiology (59.34%)
- Antibiotics (28.31%)
- Anaerobic bacteria (19.88%)
What were the highlights of his more recent work (between 2005-2020)?
- Microbiology (59.34%)
- Clostridium difficile (13.25%)
- Antibiotics (28.31%)
In recent papers he was focusing on the following fields of study:
Microbiology, Clostridium difficile, Antibiotics, Internal medicine and Antibiotic resistance are his primary areas of study.
The various areas that he examines in his Microbiology study include Vancomycin, Bacteroides and Virology.
His Clostridium difficile research includes elements of Ribotyping, Cadazolid and Metronidazole.
The concepts of his Antibiotics study are interwoven with issues in Microbiome, Avibactam, Dalbavancin and Candida albicans.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Surgery.
His study in Antibiotic resistance is interdisciplinary in nature, drawing from both Antibiotic prophylaxis, Propionibacterium acnes and Tigecycline, Antimicrobial, Anti-Infective Agents.
Between 2005 and 2020, his most popular works were:
- Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections (354 citations)
- Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces (207 citations)
- Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience (177 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Bacteria
His scientific interests lie mostly in Microbiology, Antibiotic resistance, Clostridium difficile, Drug resistance and Antibiotics.
His Microbiology study combines topics from a wide range of disciplines, such as Anaerobic bacteria and Virology.
Carl Erik Nord interconnects Internal medicine and Bacteroides in the investigation of issues within Anaerobic bacteria.
His Antibiotic resistance research incorporates themes from Propionibacterium acnes and Tigecycline.
The study incorporates disciplines such as Antimicrobial, Intensive care medicine and Metronidazole in addition to Drug resistance.
His work investigates the relationship between Antibiotics and topics such as Microbiome that intersect with problems in Metagenomics, Antibiotic prophylaxis and Gut flora.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
